CO

Cosmos Health IncNASDAQ COSM Stock Report

Last reporting period 30 Sep, 2024

Updated 25 Nov, 2024

Last price

Market cap $B

0.018

Micro

Exchange

XNAS - Nasdaq

COSM Stock Analysis

CO

Uncovered

Cosmos Health Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-58/100

Low score

Market cap $B

0.018

Dividend yield

Shares outstanding

10.605 B

Cosmos Health Inc., formerly Cosmos Holdings Inc., is a pharmaceutical company. The Company is engaged in providing nutraceuticals and distributors of pharmaceuticals, branded generics, over-the-counter (OTC) medications, and medical devices. The Company is engaged in the nutraceuticals sector through its own proprietary lines of products Sky Premium Life and Mediterranation. The Company is engaged in the pharmaceutical sector through the provision of a broad line of branded generics and OTC medications and is involved in the healthcare distribution sector through its subsidiaries in Greece and the United Kingdom serving retail pharmacies and wholesale distributors. It is also focused on the research and development (R&D) of novel patented nutraceuticals (IP) and root extracts as well as on the R&D of complex generics and OTC products. It has developed a global distribution platform. It has distribution centers in Thessaloniki and Athens, Greece and Harlow, United Kingdom.

View Section: Eyestock Rating